Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EEF1DP8 stands for "eukaryotic translation elongation factor 1 delta pseudogene 8," also known as "eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein) pseudogene, EEF1DP8." Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they do not encode active proteins and generally arise from gene duplication or retrotransposition events[3]. EEF1DP8 specifically is a non-functional copy of the gene encoding the eukaryotic translation elongation factor 1 delta, which in its active form is involved in protein synthesis. No known molecular, therapeutic, or biomarker roles are associated with EEF1DP8, and it is not a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation elongation factor 1 delta pseudogene 8 (EEF1DP8).